Open an account

Park Ha Biological Technology

BYAH · NASDAQ

$2.32−$0.04 (−1.69%)TodayMarket closed ·
Prev close $2.36

About BYAH

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 40 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.

Employees
41
Headquarters
Wuxi, Jiangsu
Listed
Dec 27, 2024
Sector
Consumer Discretionary
Industry
Specialty Retail
Website
ir.parkha.cn

BYAH key statistics

Market cap
5.44M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
234.78K
Volume
2.62K
Open price
$2.25
High today
$2.35
Low today
$2.22
52 Week high
$169.40
52 Week low
$1.90

Park Ha Biological Technology (BYAH) at a glance

As of Oct 23, 2026, Park Ha Biological Technology (BYAH) shares are priced at $2.32, giving the company a market cap of 5.44M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.22 and $2.35. The current price is 4.5% above the day's low and 1.3% below its high.

Volume so far is 2.62K shares, below the average of 234.78K shares a day.

Over the past year Park Ha Biological Technology has ranged from $1.90 to $169.40, and now sits 0% of the way up that range.

BYAH news

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH

  • Press releaseBusiness Wire

    PHH, BYAH Deadline: Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

  • Press releasePRNewswire

    SueWallSt Reminds Park Ha Biological Technology Co. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - BYAH

  • Press releasePRNewswire

    BYAH Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Park Ha Biological Technology Co. Securities Lawsuit - Contact Levi & Korsinsky

  • Press releasePRNewswire

    PHH, BYAH Deadline: PHH, BYAH Investors with Losses in Excess of $100K Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit

  • Press releasePRNewswire

    BYAH Deadline Alert: SueWallSt Reminds Park Ha Biological Technology Co. (BYAH) Investors of Securities Class Action Deadline on September 28, 2026

  • 12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

  • Press releasePRNewswire

    BYAH UPCOMING DEADLINE: Levi & Korsinsky Alerts Park Ha Biological Technology Co., Ltd. Stockholders of Securities Class Action - Contact the Firm

Similar companies

Companies in the same industry as Park Ha Biological Technology

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.